Growth Metrics

InspireMD (NSPR) Net Income towards Common Stockholders Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 98.96%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.60%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -30.10%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 InspireMD 64.01 Mn 9.80 Mn 1.18 Mn 56.64%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 56.64%
Sep 30, 2025 -54.23%
Jun 30, 2025 -57.62%
Mar 31, 2025 -54.57%
Dec 31, 2024 400.05%
Sep 30, 2024 -50.06%
Jun 30, 2024 -55.41%
Mar 31, 2024 -69.23%
Dec 31, 2023 -20.57%
Sep 30, 2023 -24.51%
Jun 30, 2023 -14.65%
Mar 31, 2023 2.23%
Dec 31, 2022 -18.88%
Sep 30, 2022 -11.25%
Jun 30, 2022 -32.19%
Mar 31, 2022 -38.17%
Dec 31, 2021 -8.98%
Sep 30, 2021 -85.47%
Jun 30, 2021 -41.41%
Mar 31, 2021 -60.47%
Dec 31, 2020 -46.78%
Sep 30, 2020 -6.04%
Jun 30, 2020 -12.42%
Mar 31, 2020 36.98%
Dec 31, 2019 -11.98%
Sep 30, 2019 -2.93%
Jun 30, 2019 -113.35%
Mar 31, 2019 -34.24%
Dec 31, 2018 58.54%
Sep 30, 2018 3.60%
Jun 30, 2018 54.93%
Mar 31, 2018 6.64%
Dec 31, 2017 -140.56%
Sep 30, 2017 -4.56%
Jun 30, 2017 -17.88%
Mar 31, 2017 -13.63%
Dec 31, 2016 20.53%
Sep 30, 2016 45.21%
Jun 30, 2016 49.82%
Mar 31, 2014 -22.17%
Sep 30, 2013 47.44%
Mar 31, 2013 -55.57%
Dec 31, 2012 76.68%
Sep 30, 2012 -228.78%
Mar 31, 2012 -65.70%
Dec 31, 2011 -597.12%
Sep 30, 2011 -169.54%
Jun 30, 2011 -239.97%